Palmero Iii, Bernardo R.
HRN: 27-87-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFTRIAXONE 1G (VIAL)
09/28/2025
10/04/2025
IV
570mg
Q12H
PCAP C
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes